Moreover, to identify whether apoptosis was specifically regulated by caspase-3 activation, we evaluated the level of cleaved PARP and caspase-3 in AZD4573-treated breast cancer cells and cells treated with 50 μM of a pan-caspase inhibitor, Z-VAD-FMK [52]. Here, CASP3 is linked to breast carcinoma.